Somagenetix (private company)
See something wrong or missing? Let us know
Offices:Zurich
Industry:BiotechHealth services
Business model:B2B
Somagenetix is a Swiss gene therapy startup working with and using genetically modified phagocytes to treat patients suffering from immunodeficiency, neurodegeneration, and cancer with brain metastases.
Investors:
we tracked 4 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 11.8M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Somagenetix
| Name | Criteria | |
|---|---|---|
![]() |
AbolerIS Pharma
53%
|
|
![]() |
Acesion Pharma
53%
|
|
![]() |
Achilles Therapeutics
53%
|
|
![]() |
Aprea Therapeutics
53%
|
|
![]() |
Arthex Biotech S.L.
53%
|
|
![]() |
Atai Life Sciences
53%
|
|
![]() |
Biofidelity
53%
|
|
![]() |
BoneSupport
53%
|
|
![]() |
CatalYm
53%
|
|
![]() |
Cinclus Pharma
53%
|
|







Belgium
Netherlands
Austria
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Italy
Portugal